Literature DB >> 139225

Plasma glucose, non-esterified fatty acids and amino acids in Huntington's chorea.

O T Phillipson, E D Bird.   

Abstract

1. The metabolic responses to an oral glucose tolerance test (100 g) and an intravenous insulin provocation test (0-1 i.u./kg) were studied in nine control subjects and nine patients with Huntington's chorea. 2. Plasma glucose responses to these stimuli were identical in both groups. 3. High fasting concentrations of non-esterified fatty acid (NEFA) were recorded in the choreic patients when compared with control subjects. This difference was maintained under hypoglycaemic conditions. However, during hyperglycaemia the differences in NEFA concentrations between the groups was abolished. 4. Total plasma tryptophan concentrations were equal in the two groups. Free plasma tryptophan, however, was markedly reduced in the choreic group, and this appeared to be a result of a disturbed relationship between free tryptophan and NEFA concentrations. The abnormalities in free tryptophan values were sensitive to plasma glucose concentrations, as hyperglycaemic conditions markedly reduced the differences between the choreic and control group. 5. Patients with Huntington's chorea showed reduced fasting plasma concentrations of leucine, isoleucine and valine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 139225     DOI: 10.1042/cs0520311

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  6 in total

1.  Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease.

Authors:  Korrapati V Sathyasaikumar; Erin K Stachowski; Laura Amori; Paolo Guidetti; Paul J Muchowski; Robert Schwarcz
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

2.  Transcriptional control of amino acid homeostasis is disrupted in Huntington's disease.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-19       Impact factor: 11.205

3.  Cystathionine Levels in Patients With Huntington Disease.

Authors:  N A Aziz; W Onkenhout; H J Kerstens; Raymund A C Roos
Journal:  PLoS Curr       Date:  2015-09-16

4.  Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.

Authors:  Fanny Mochel; Perrine Charles; François Seguin; Julie Barritault; Christiane Coussieu; Laurence Perin; Yves Le Bouc; Christiane Gervais; Guislaine Carcelain; Anne Vassault; Josué Feingold; Daniel Rabier; Alexandra Durr
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

5.  A Metabolic Study of Huntington's Disease.

Authors:  Rajasree Nambron; Edina Silajdžić; Eirini Kalliolia; Chris Ottolenghi; Peter Hindmarsh; Nathan R Hill; Seán J Costelloe; Nicholas G Martin; Vincenzo Positano; Hilary C Watt; Chris Frost; Maria Björkqvist; Thomas T Warner
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

Review 6.  A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.

Authors:  Edina Silajdžić; Maria Björkqvist
Journal:  J Huntingtons Dis       Date:  2018
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.